RT Journal Article
SR Electronic
T1 Novel insights into the common heritable liability to addiction: a multivariate genome-wide association study
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.11.19.21266548
DO 10.1101/2021.11.19.21266548
A1 Schoeler, Tabea
A1 Baldwin, Jessie
A1 Allegrini, Andrea
A1 Barkhuizen, Wikus
A1 McQuillin, Andrew
A1 Pirastu, Nicola
A1 Kutalik, Zoltán
A1 Pingault, Jean-Baptiste
YR 2021
UL http://medrxiv.org/content/early/2021/11/19/2021.11.19.21266548.abstract
AB Addiction to nicotine, alcohol and cannabis commonly co-occurs, which is thought to partly stem from a common heritable liability. To elucidate its genetic architecture, we modelled the common liability to addiction, inferred from genetic correlations among six measures of dependence and frequency of use of nicotine, alcohol and cannabis. Forty-two genetic variants were identified in the multivariate genome-wide association study on the common liability to addiction, of which 67% were novel and not associated with the six phenotypes. Mapped genes highlighted the role of dopamine (e.g., dopamine D2 gene), and showed enrichment for several components of the central nervous systems (e.g., mesocorticolimbic brain regions) and molecular pathways (dopaminergic, glutamatergic, GABAergic) that are thought to modulate drug reinforcement. Genetic correlations with other traits were most prominent for reward-related behaviours (e.g., risk-taking, cocaine and heroin use) and mood (e.g., depression, insomnia). These genome-wide results triangulate and expand previous preclinical and human studies focusing on the neurobiological substrates of addiction, and help to elucidate the common genetic architecture underlying addiction.Competing Interest StatementThe authors have declared no competing interest.Funding StatementT.S. is funded by a Wellcome Trust Sir Henry Wellcome fellowship (grant 218641/Z/19/Z)Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesSummary statistics of the common liability GWA analysis will be available upon publication of this work. References to all publicly available summary statistic files included in this work are listed in sTable 1. https://github.com/TabeaSchoeler/TS2021_CommonLiabAddiction